RBIs Surprise Rate Cut Raises Questions on Policy Framework Nomura Says Jim Cramer Unveils Morning Meeting Picks Bullish Calls and Potential 30 Upside Stock Senco Gold Q4 Profit Surges 151 on Record Retail Sales and Soaring Gold Prices Airtel Defends Priority Postpaid Plan Before DoT Panel Cites Regulatory Framework for Network Slicing Best Buy Shares Rise as New Product Launches and Higher Tax Refunds Drive Sales Applied Digital Releases Fiscal Third Quarter 2026 Results Focus on AI Infrastructure Growth BTBT Q1 2026 Earnings Massive EPS Miss as Bit Digital Reports DeeperThanExpected Loss VALN Q1 2026 Earnings EPS Misses Expectations Amid Ongoing Operational Challenges Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development BOBS Q1 2026 Earnings EPS Surges Past Estimates Shares Dip Despite Strong Beat DBRG Q1 2026 Earnings EPS Falls Short of Estimates Amidst Operational Headwinds Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline NexPoint Residential Trust NXRT Posts Modest Uptick Amid Steady Multifamily Demand Starfighters Space Inc FJET Slides 569 as Selling Pressure Intensifies USA Compression Partners USAC Retreats Slightly as Stock Holds Above Key Support US Physical Therapy USPH Gains 332 as Stock Tests Resistance Levels Nuveen SP 500 Dynamic Overwrite Fund SPXX Edges Higher Key Levels in Focus Foreign Land Purchases in the Caribbean Raise Coastal Access Concerns Dropbox Q1 2026 Earnings EPS Surpasses Estimates on Improved Operating Efficiency PDF Solutions Surges 527 as Shares Test Key Resistance Levels SCM Q1 2026 Earnings EPS Misses Estimates Stock Declines Slightly Visa Q1 2026 Earnings EPS Beats Estimates by Nearly 5 Shares Dip Slightly BELFA Q1 2026 Earnings EPS Surpasses Estimates Stock Rises on Strong Performance TTD Q1 2026 Earnings EPS Misses Estimates But Stock Climbs on Strong Operational Momentum MTUS Q1 2026 Earnings EPS Surprise Drives Stock Higher Kyntra Bio Inc KYNB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates as Stock Edges Higher QRHC Q1 2026 Earnings EPS Miss Highlights Operational Headwinds and Cost Pressures